Features

Simon Williams, Head of Communications and Policy at Heart UK, discusses the threat posed by cholesterol in the development of cardiovascular...

Pharmaceutical production has long been the object of scrutiny to ensure the highest levels of quality and safety are maintained. However, a new...

Through digital media and technology, the patient’s voice is only growing in strength and it is of growing importance that pharmaceutical industry...

Updated annually, the BP is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and...

Daniel Ray, Head of NHS Digital discusses the importance of data usage in the healthcare system and the NHS Digital cyber security team responds...

The departure of the United Kingdom from the European Union, dubbed “Brexit,” has sparked significant economic global uncertainty, with two...

Sanofi’s Riccardo Perfetti, Head of Global Diabetes, and Jukka Westerbacka, Medical Director, Global Medical Affairs, discuss how the significance...

Intrigued about how your approach to webinars compares with your peers in the pharma industry? To provide a snapshot of the current use of this...

The development of innovative treatments for neurological disorders such as dementia has stagnated over the past decade despite being an area of...

Gustaf Duhs, Partner at Stevens & Bolton, discusses the recent cases of regulators becoming firmer with drug companies over their drug pricing...